President Donald Trump announced Thursday that brand-name or patented pharmaceutical products will face a 100% tariff starting Oct. 1, with exemptions for companies building manufacturing plants in the U.S., while Asian pharmaceutical stocks declined Friday.
Trump Announces 100% Tariffs on Pharma Imports